SUmmARY Single oral doses of propranolol (120 mg), metoprolol (150 mg) and placebo were given in a randomised, double-blind fashion to 23 patients with essential tremor. Both blockers were significantly more effective than placebo in reducing the magnitude of tremor. The decrease in tremor produced by metoprolol (47, sem 9 %, n = 23) was not significantly different from that observed after propranolol (55, sem 5%, n = 23). Tachycardia on standing was antagonised by both drugs to a similar extent. These findings suggest that metoprolol may represent a valuable alternative to propranolol in the treatment of essential tremor. The data is consistent with the hypothesis that the tremorolytic effect of blockers in these patients may be unrelated to peripheral /3-2 adreno-receptor blockade, being possibly mediated by other central or peripheral modes of action of these drugs. However, it cannot be excluded that at the dose used, metoprolol had lost its relative cardio-selectivity and that the reduction in tremor wasmediatedbycompetitive antagonism at /3-2 receptor sites in skeletal muscle.
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Essential tremor, with its familial and senile varieties, is a tremor of posture and action mostly involving the upper limbs which usually develops in adult life in the absence of other demonstrable neurological abnormalities.' 2 The frequency of the tremor is usually quoted as ranging from 5-9 Hz3 and, as with all tremulous disorders, its amplitude is exacerbated by anxiety and stress. In spite of being classified as benign, in some patients the tremor may be severe enough to disrupt occupational and social activities. Alcohol can be effective in reducing the amplitude of this tremor,4 but this therapy is impracticable because of the risk of addiction and other medical problems.
To date, the drug which has been proven to be of greatest therapeutic benefit is propranolol.5-8 The mechanism by which propranolol exerts its therapeutic effect in essential tremor is incompletely understood. Many authors accept that the reduction in tremor is mediated predominantly by blockade of peripheral beta adrenergic receptors6 9 but other sites of action have also been postulated.'0 11 In a recent double-blind study, atenolol, a cardio-selective /3 blocking drug, which therefore has preferential action on /-1 receptors, was found to be less effective than either propranolol or sotalol, two non-selective /3 blockers, on reducing the severity of tremor.12 This data was interpreted as evidence that the therapeutic effect of ,B blockers on essential tremor is mediated by the action on peripheral /-2 receptors. This conclusion has recently been challenged following reports that metoprolol, another cardio-selective drug, can be highly effective in reducing tremor in some patients.13-17 Unfortunately, most of these later reports are based on uncontrolled clinical observations and do not provide a reliable estimate of the relative efficacy of metoprolol in the treatment of essential tremor.
In the present paper we report the results of a double-blind, placebo controlled study on the comparative effect of a single oral dose of metoprolol and propranolol in patients with essential tremor.
Methods

Patients
Twenty-three patients with essential tremor (15 In each patient only the data obtained from the more affected hand was used for computation of results. It was interesting to note that in three patients the more involved hand differed from one session to another. An example of computer "print out" of tremor analysis before and after a single oral dose of metoprolol is illustrated in fig 1. Statistical analysis Values of tremor magnitude were compared by using the Wilcoxon's test for paired differences. Statistical analysis of heart rate and blood pressure values were performed by using the Student's t test for paired data. For testing the correlation between the reduction oftremor magnitude and the inhibition of standing tachycardia, Spearman rank correlation coefficient was used.
Results
TREMOR
The frequency of the dominant peak of the hand tremor of the patients included in the study ranged from 4-3 to 8 5 Hz. In any single patient the frequency was similar in all pre-drug recordings and did not change significantly after the administration of the P blockers. Prior to drug administration the peak magnitude of tremor ranged from 3-2 to 920g x 10-3 and showed considerable variation between and within patients on different occasions of recording. However, within any single pre-drug recording session there was little fluctuation in tremor magnitude.
After the administration of placebo, the magnitude of tremor decreased in 14 patients, increased in three patients and remained unchanged in six (that is, showed a change of less than 15 %). Following the administration of propranolol, the tremor decreased in 20 patients and remained substantially unchanged in two (one patient who had received metoprolol and placebo was lost to follow-up and his response to propranolol could not be studied). Administration of metoprolol was associated with a reduction in tremor magnitude in 20 patients and an increase in three patients (fig 2) . On average the magnitude of tremor decreased by 22 ± 7*3 % (sem) after placebo (NS), by 55 ± 5.0% (sem) after propranolol (p < 0-01) and by 47 ± 9*7% (sem) after metoprolol (p < 0 01) ( fig. 3) Propranolol and metoprolol diminished the normal increase in pu!se rate on standing (p < 0 01) whereas placebo had no effect (fig 4) . The reduction in standing tachycardia produced by metoprolol was similar to that observed after propranolol. There was no significant correlation between reduction in tremor magnitude and the inhibition of 
Discussion
The present study provides the first clear demonstration that a single oral dose of either propranolol or metoprolol is significantly better than placebo in reducing the magnitude of essential tremor. Both 3 blockers reduced the tremor magnitude to approximately 50 % of the base-line value. A moderate (but statistically non-significant) improvement in tremor, however, was also seen after the administration of placebo, an observation that emphasises the importance of using a controlled designed trial if a reliable estimate of drug efficacy is to be obtained. A mode of action unrelated to P-2 adrenoceptor blockade is suggested by isolated clinical reports that relatively low doses of metoprolol can relieve essential tremor without exacerbating respiratory symptoms in patients with asthma or chronic obstructive airways disease.14-'6 It cannot be excluded, however, that /-2 adrenergic receptors in skeletal muscle are blocked at doses of metoprolol lower than those required to block the same type of receptors in the bronchial muscles.
The experimental design used in this study provides a potentially useful approach to the evaluation of the efficacy of P adrenoceptor blocking drugs in essential tremor. One important aspect that needs to be examined in future studies is whether the effect observed after a single dose can be used to predict the pharmacological response to chronic administration. Several authors have previously commented on the fact that some patients are apparently refractory to chronic propranolol therapy while others respond particularly well.'2 16 Although so far no reliable predictive criterion of response has been recognised in these patients, the suggestion has been made that patients with higher peak frequencies of tremor may show a comparatively less favourable response.26 27 In our study all patients with tremor frequency below 8 Hz improved after propranolol whereas of the three patients with tremor frequencies above 8 Hz, two failed to respond. With metoprolol the differential effect according to tremor frequency was less clear. These observations concerning the relationship between frequency and responsiveness may have important therapeutic and pathophysiological implications and deserves further evaluation.
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